CXCL9 and neoplasm: Nanostring nCounter IO 360 analysis (23) indicated that RXC004 significantly increased the overall tumor-associated CD45+ immune cells, including dendritic cells, and increased tumor expression of the chemokine CXCL9 in this B16F10 model (Fig. 5F–H).